Phospho-eIF2Bε links stress response-driven translation to amyloidogenesis in Alzheimer’s disease

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

A central aetiopathological event in Alzheimer’s disease is the accumulation of amyloid β-peptide (Aβ) derived from the amyloidogenic processing of the amyloid precursor protein, a pathway initiated by BACE1. Chronic activation of the Integrated Stress Response is linked to Alzheimer’s disease, typically through eIF2α phosphorylation, which selectively enhances translation of key stress-responsive mRNAs like ATF4 and BACE1. We investigated a novel regulatory mechanism mediated by Glycogen Synthase Kinase-3β (GSK-3β) a hyperactive kinase in Alzheimer’s disease, on the translational factor eIF2B, the guanine nucleotide exchange factor (GEF) for eIF2. We treated human neuroblastoma cells (SH-SY5Y) with a GSK-3β inhibitor (NP031112) or overexpressed a constitutively active GSK-3β mutant (GSK-3β-S9A) on HEK cells to modulate GSK-3β activity. GSK-3β inhibition significantly reduced ATF4 and BACE1 protein levels in SH-SY5Y cells in a dose-dependent manner as we tested by western blot ( P <0.001), independent of eIF2α phosphorylation. This effect was translational, as the inhibitor still reduced BACE1 levels when transcription was blocked. Crucially, NP031112 reversed stress-induced eIF2Bε phosphorylation at Ser540 ( P <0.001). Furthermore, H 2 O 2 -induced Aβ 1-42 secretion by SH-SY5Y cells was significantly reversed by GSK-3β inhibition ( P <0.001). Luciferase reporter assays using the BACE1 5’ untranslated region (5’ UTR) confirmed that both eIF2Bε silencing and a phosphomimetic mutant eIF2Bε-S540E increased BACE1 5’ UTR-driven translation ( P <0.001), demonstrating that reduced functional eIF2B enhances BACE1 translation. Finally, immunohistofluorescence and western blot analysis of human AD hippocampi confirmed the translational link, showing a significant increase in pS540-eIF2Bε, ATF4, and BACE1 levels in AD patients compared to non-demented controls ( P <0.001 for all three). Our findings establish a novel GSK-3β-eIF2Bε-BACE1 axis that links stress response dysregulation to amyloidogenesis, independent of canonical eIF2α phosphorylation. The phosphorylation of eIF2Bε functionally mimics the effects of eIF2α phosphorylation by reducing the available functional eIF2B pool, thereby reprogramming translation to favour the production of stress proteins like ATF4 and BACE1. Based on our results, we proposed that eIF2Bε phosphorylation is a key etiological mechanism in Alzheimer’s disease.

Article activity feed